Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biontech Se ADR
(NQ:
BNTX
)
111.77
-2.70 (-2.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
64
65
Next >
Wall Street Thinks These 2 Undervalued Stocks Have Exceptional Growth Potential
March 10, 2023
They're both facing the same fierce headwind, and it won't be going away soon.
Via
The Motley Fool
How Much Did US Government Spend On mRNA Vaccine Technology Before And During The Pandemic? The Number Can Be Surprising
March 03, 2023
Via
Benzinga
European Commission Keeps Mum On Talks Regarding Pfizer COVID-19 Vaccine Contract: Report
March 02, 2023
European Commission President Ursula von der Leyen remains silent on her dealings with Pfizer Inc (NYSE: PFE) regarding the EU's COVID-19 vaccine contract is hurting public trust.
Via
Benzinga
BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel
March 01, 2023
From
BioNTech SE
Via
GlobeNewswire
Overview Of Value Stocks In The Healthcare Sector
February 20, 2023
Via
Benzinga
Analyst Ratings for BioNTech
January 24, 2023
Via
Benzinga
The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks
February 24, 2023
Startling cancer vaccine results from Moderna may point to the next big thing in biotech.
Via
Investor's Business Daily
Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination
February 24, 2023
Via
Benzinga
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
February 23, 2023
The company is doubling down on its vaccine success.
Via
The Motley Fool
Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees
February 17, 2023
Shares crumbled after Moderna's flu shot outperformed in just one flu strain.
Via
Investor's Business Daily
Why Is Moderna (MRNA) Stock Down 5% Today?
February 17, 2023
If Moderna's new formulation works the latest failure will be a short-term hiccup. But MRNA stock also faces legal and PR challenges.
Via
InvestorPlace
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
February 17, 2023
Via
Benzinga
Is Novavax Stock a Buy With the New Normal for COVID?
February 10, 2023
The landscape has shifted dramatically in the COVID-19 vaccine market.
Via
The Motley Fool
The 3 Most Undervalued Growth Stocks for Your February Buy List
February 06, 2023
These undervalued growth stocks have the value and projected growth that investors seek when researching their next investment decisions.
Via
InvestorPlace
Better Buy: Novavax or BioNTech Stock?
February 04, 2023
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.
Via
The Motley Fool
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.
Via
InvestorPlace
BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility
February 02, 2023
From
BioNTech SE
Via
GlobeNewswire
Novavax Shares Jumped in January While Others Slipped
February 01, 2023
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.
Via
MarketBeat
Exposures
COVID-19
Product Safety
Why BioNTech And Moderna Shares Are Falling After Pfizer News
January 31, 2023
BioNTech SE - ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer Inc. (NYSE:
Via
Benzinga
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths.
Via
Benzinga
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
January 27, 2023
The FDA's experts voted in favor of annual boosters on Thursday.
Via
Investor's Business Daily
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26, 2023
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.
Via
MarketBeat
Exposures
Product Safety
Thursday Predictions: 3 Hot Stocks for Tomorrow
January 25, 2023
Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why.
Via
InvestorPlace
COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today
January 23, 2023
The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19.
Via
Benzinga
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20
January 20, 2023
Here's a round-up of stories from around the globe and from various media outlets. Benzinga
Via
Benzinga
Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots
January 20, 2023
Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).
Via
Benzinga
Pfizer (PFE) Stock Falls on Analyst Downgrade
January 17, 2023
Although Pfizer led the charge in forwarding Covid-19 solutions, possibly waning relevancy poses serious concerns for PFE stock.
Via
InvestorPlace
Pfizer Stock Dives As Analyst Calls For 'Covid Reset' And Downgrades Shares
January 17, 2023
Shares have skidded almost 10% in the first two weeks of 2023.
Via
Investor's Business Daily
US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People
January 16, 2023
The U.S.
Via
Benzinga
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
January 13, 2023
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.
Via
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
64
65
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.